Known Compound 3. 5 1-Deoxyglucosamine hydrochloride. 1.2 (2.50 g, 7.55 mmol) was dissolved in 2.5 M HCl (20 mL) and refluxed for 2 h. Upon completion the mixture was concentrated. The resulting oil was dissolved in minimal EtOH and Et2O was added under stirring until the product precipitated and was filtered and washed with isopropanol to yield the product as an off-white powder (1.14 g, 75% yield). 1 To the starting material was added TEA (183 µL, 1.31 mmol) and the reaction proceeded for 10 min. 4-Pentynoic acid (147 mg, 1.50 mmol) followed by N,N'-Dicyclohexylcarbodiimide (309 mg, 1.50 mmol) were then added followed by a catalytic amount of DMAP (~5 mg). The starting material slowly went in to solution and the reaction proceeded for 16 h. Upon completion, the reaction mixture was concentrated under reduced pressure and purified by column chromatography (10% MeOH in CH2Cl2). The purified product was then resuspended in pyridine (5 mL) and acetic anhydride (1.5 mL) and allowed to stir for 16 h. Upon completion the reaction was concentrated, resuspended in CH2Cl2, washed with 1M HCl (1x), saturated NaHCO3 (1x), H2O (1x), and Brine (1x). The organic layer was dried over Na2SO4, filtered and concentrated. The crude mixture was then purified over silica-gel chromatography 50-60% EtOAc in Hexanes to afford crude (154 mg, 33% yield over 2 steps). 1 Compound 5. 1-Deoxy-N-4-pentynylglucosamine (1-deoxy-GlcNAlk). 1.4 (154 mg, 0.417 mmol) was dissolved in MeOH (10 mL). Freshly prepared NaOMe (Na in MeOH) was added dropwise to reach pH 9-10. The reaction was monitored TLC and determined finished in 1 h. The reaction was quenched with dilute acetic acid in MeOH until pH 7 reached. The mixture was then concentrated and column chromatograpy (10% MeOH in CH2Cl2) yielded the pure product (85 mg, 84% yield). 1 H NMR (500 MHz, CD3OD) δ 3.91 (dd, J = 10.9, 5.2 Hz, 1H), 3.87 -3.77 (m, 2H), 3.62 (dd, J = 11.9, 6.0 Hz, 1H), 3 Cell Culture COS-7, HEK293, HeLa and MCF7 cells were cultured in high-glucose DMEM media (Corning) enriched with 10% fetal bovine serum (v/v, HyClone, ThermoScientific). NIH3T3 and MEF cells were cultured in high-glucose DMEM media (Corning) enriched with 10% fetal calf serum (v/v, HyClone, ThermoScientific). H1299 cells were cultured in RPMI media enriched with 10% fetal bovine serum (v/v, HyClone, ThermoScientific). All cell lines were maintained in a humidified incubator at 37 °C and 5.0% CO2.
Metabolic labeling
To cells at 80-85% confluency, media containing 1-deoxy-Ac3GlcNAlk, Ac4GlcNAlk (1,000 x stock in DMSO) or 1-deoxy-GlcNAlk (dissolved directly in media) or DMSO vehicle was added as indicated. For chase experiments, media was replaced with media supplemented with 1deoxy-Ac3GlcNAc (200 μM, 1,000 x stock in DMSO).
Preparation of NP-40-soluble lysates
The cells were then collected by trypsinization and pelleted by centrifugation at for 4 min at 500 x g, followed by washing 2x with PBS (1 mL). Cell pellets were then resuspended in 100 μl of 1% NP-40 lysis buffer [1% NP-40 (w/v), 150 mM NaCl, 50 mM triethanolamine (TEA) pH 7.4] with Complete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets (Thermo Scientific) for 20 min and then centrifuged for 10 min at 10,000 x g at 4 °C. The supernatant (soluble cell lysate) was collected and the protein concentration was determined by BCA assay (Pierce, ThermoScientific).
Preparation of 4%-soluble lysates
Cells were collected by trypsinization and pelleted by centrifugation for 4 min at 500 x g, followed by washing 2x with PBS (1 mL). Cell pellets were then resuspended in 1esuspended in 75 μL 0.05% SDS buffer (0.05% SDS (w/v), 10 mM TEA pH 7.4, 150 mM MgCl2) with Complete Mini protease inhibitor cocktail (Roche Biosciences). To this was added 1 μL Benzonase (Sigma), and the cells were incubated on ice for 30 min. Then, 200 μL 4% SDS buffer (4% SDS (w/v), 150 mM NaCl, 50 mM TEA pH 7.4) was added, and the cells were briefly sonicated in a bath sonicator followed by centrifugation (20,000 x g for 10 min at 15 °C). Soluble protein concentration was normalized by BCA assay (Pierce, ThermoScientific) to 1 mg mL -1 .
Cu(I)-catalyzed [3 + 2] azide-alkyne cycloaddition (CuAAC)
Cell lysate (200 μg) was diluted with cold 1% NP-40 lysis buffer to obtain a desired concentration of 1 μg μL -1 . Newly made click chemistry cocktail (12 μL) was added to each sample [azido-or alkynyl-rhodamine tag (100 μM, 10 mM stock solution in DMSO); tris(2carboxyethyl)phosphine hydrochloride (TCEP) (1 mM, 50 mM freshly prepared stock solution in water); tris[(1-benzyl-1-H-1,2,3-triazol-4-yl)methyl]amine (TBTA) (100 μM, 10 mM stock solution in DMSO); CuSO4•5H2O (1 mM, 50 mM freshly prepared stock solution in water) for a total reaction volume of 200 μL. The reaction was gently vortexed and allowed to sit at room temperature for 1 h. Upon completion, 1 mL of ice cold methanol was added to the reaction, and it was placed at -20 °C for 2 h to precipitate proteins. The reactions were then centrifuged at 10,000 x g for 10 min at 4 . The supernatant was removed, the pellet was allowed to air dry for 15 min, and then 50 μL 4% SDS buffer (4% SDS (w/v), 150 mM NaCl, 50 mM TEA pH 7.4) was added to each sample. The mixture was sonicated in a bath sonicator to ensure complete dissolution, and 50 μL of 2x SDS-free loading buffer (20% glycerol (v/v), 0.2% bromophenol blue (w/v), 1.4% β-mercaptoethanol (v/v), pH 6.8) was then added. The samples were boiled for 5 min at 97 °C, and 40 μg of protein was then loaded per lane for SDS-PAGE separation (Any Kd, Criterion Gel, Bio-Rad).
In-gel Fluorescence Scanning. Following SDS-PAGE separation, gels were scanned on a Typhoon 9400 Variable Mode Imager (GE Healthcare) using a 532 nm for excitation and 30 nm bandpass filter centered at 610 nm for detection.
Metabolic labelling comparison of Sodium Pentynoate and 1-deoxy-Ac3GlcNAlk.
MEFs were treated with 0.2 mM, 5 mM or DMSO vehicle for 6 h. Upon treatment completion, cells were washed, trypsinized and pelleted. Cell pellets were washed 3x with PBS, lysed with 1% NP-40 buffer and soluble lysate subjected CuAAC with azido-rhodamine as described in the Methods section of the main text.
Competition of 1-deoxy-Ac3GlcNAlk labelling with NaOAc.
NIH-3T3 cells were treated with or without NaOAc (10 mM) and 1-deoxy-Ac3GlcNAlk (200 µM) for 6 h. Cells were then lysed by 4% SDS buffer with benzonase as outlined in the methods section in the main text .
Inhibition of histone acetyl transferases by curcumin.
NIH-3T3 cells were treated with or without curcumin (60 µM) for 30 min prior to treatment with 1-deoxy-Ac3GlcNAlk (200 µM) for 5.5 h. Cells were then lysed by 4% SDS buffer with benzonase as outlined in the methods section in the main text.
MTS Assay
MEFs (10 4 ) plated 4 h prior in a 96-well plate were treated for 24 or 48 h with either 1-deoxy-Ac3GlcNAlk (200 µM) or DMSO vehicle in triplicate. Upon treatment completion, cell viability was determined by MTS assay according to literature procedure (CellTiter 96 AQeous Non-Radioactive Cell Proliferation Assay, Promega, Madison, WI) with the following minor change. After sufficient color development, a reaction-quenching formazan-solubilization solution (100 µL) was added to each well (50% DMF (v/v), 20% SDS (w/v) in H2O). Absorbance at 490 nm was read using a BioTek Synergy H4 Multi-Mode Microplate reader.
Biotin Enrichment and On-bead Trypsinolysis.
NIH-3T3 cell pellets labeled with 1-deoxy-Ac3GlcNAlk, Ac4GlcNAlk or 1-deoxy-Ac3GlcNAc for 16 hours were resuspended in 200 µL H2O, 60 µL PMSF in H2O (250 mM), and 500 µL 0.05% SDS buffer (0.05% SDS (w/v), 10 mM TEA pH 7.4, 150 mM MgCl2) with Complete Mini protease inhibitor cocktail (Roche Biosciences). To this was added 8 µL Benzonase (Sigma), and the cells were incubated on ice for 30 min. Then, 2000 µL 4% SDS buffer (4% SDS (w/v), 150 mM NaCl, 50 mM TEA pH 7.4) was added, and the cells were briefly sonicated in a bath sonicator followed by centrifugation (20,000 x g for 10 min at 15 °C). Soluble protein concentration was normalized by BCA assay (Pierce, ThermoScientific) to 1 mg mL -1 , and 10 mg of total protein was subjected to the appropriate amount of click chemistry cocktail containing azido-PEG3-biotin (5 mM, Click Chemistry Tools) for 1 h, after which time 10 volumes of ice-cold MeOH were added. Precipitation proceeded 2 hours at -20 °C. Precipitated proteins were centrifuged at 5,200 x g for 30 min at 0 °C and washed 3 times with 40 mL ice-cold MeOH, with resuspension of the pellet each time. The pellet was then air-dried for 1 h. To capture the biotinylated proteins by streptavidin beads, the air-dried protein pellet was resuspended in 2 mL of resuspension buffer (6 M urea, 2 M thiourea, 10 mM HEPES pH 8.0) by bath sonication. To cap cysteine residues, 100 µl of freshly-made TCEP (200 mM stock solution, Thermo) was then added and the mixture incubated for 30 min, followed by 40 µl of freshly prepared iodoacetamide (1 M stock solution, Sigma) and incubation for a further 30 min in the dark. Streptavidin beads (250 µL of a 50% slurry per sample, Thermo) were washed 2x with 1 mL PBS and 1x with 1 mL resuspension buffer and resuspended in resuspension buffer (200 µL). Each sample was combined with streptavidin beads and incubated on a rotator for 2 h. These mixtures were then transferred to Mini Bio-Spin® columns (Bio-Rad) and placed on a vacuum manifold. Captured proteins were then washed with agitation 5x with resuspension buffer (10 mL), 5x PBS (10 mL), 5x with 1% SDS (w/v) in PBS (10 mL), 30x with PBS (1 mL per wash, vacuum applied between each wash), and 5x 2M urea in PBS (1 mL per wash, vacuum applied between each wash). Beads were then resuspended in 2 M urea in PBS (1 mL), transferred to screw-top tubes, and pelleted by centrifugation (2000 x g for 2 min). At this time, 800 µL of the supernatant was removed, leaving a volume of 200 µL. To this bead-mixture was added 2 µL of CaCl2 (200 mM stock, 1 mM final concentration) and 2 µL of 1 mg mL -1 sequence grade trypsin (Promega) and incubated at 37 °C for 18 hours. The resulting mixtures of tryptic peptides and beads were transferred to Mini Bio-Spin® columns (Bio-Rad) and the eluent was collected by centrifugation (1,000 x g for 2 min). Any remaining peptides were eluted by addition of 100 µL of 2 M urea in PBS followed by centrifugation as immediately above. The tryptic peptides were then applied to C18 spin columns (Pierce) according to manufacturer's instructions, eluted with 70% acetonitrile in H2O, and concentrated to dryness on a speedvac.
LC-MS/MS Analysis.
Peptides were desalted on a trap column following separation on a 12cm/ 75µm reversed phase C18 column (Nikkyo Technos Co., Ltd.). A 3 hour gradient increasing from 10% B to 45% B in 3 hours (A: 0.1% Formic Acid, B: Acetonitrile/0.1% Formic Acid) was delivered at 150 nL min -1 . The liquid chromatography setup (Dionex) was connected to an Orbitrap XL (Thermo) operated in top-5-mode. Acquired tandem MS spectra (CID) were extracted using ProteomeDiscoverer v. 1.3 (Thermo) and queried against the human Uniprot protein database using MASCOT 2.3.02 (Matrixscience). Peptides fulfilling a Percolator calculated 1% false dis- 
